We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Acrivon Therapeutics
ACRV
$74M
| $7.74M | 0.02% |
597,469
| – | – |
|
827
Centene
CNC
$32.5B
| $7.73M | 0.02% |
+114,599
| New | +$7.64M |
|
828
Shift4
FOUR
$3.26B
| $7.71M | 0.02% |
113,596
-467,407
| -80% | -$30.6M |
|
829
Unity
U
$18.9B
| $7.7M | 0.02% |
+177,341
| New | +$5.68M |
|
830
Palomar
PLMR
$3.45B
| $7.68M | 0.02% |
132,279
+120,630
| +1,036% | +$6.45M |
|
831
International Paper
IP
$22B
| $7.67M | 0.02% |
+241,064
| New | +$7.9M |
|
|
ZINGW
832
CALL
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
| $7.67M | 0.02% |
735,000
| – | – |
|
|
ATSG
833
DELISTED
Air Transport Services Group
ATSG
| $7.64M | 0.01% |
404,746
+298,558
| +281% | +$5.55M |
|
834
Vital Farms
VITL
$525M
| $7.62M | 0.01% |
635,318
+113,810
| +22% | +$1.59M |
|
835
Grupo Aeroportuario del Pacifico
PAC
$13.3B
| $7.61M | 0.01% |
42,575
+17,685
| +71% | +$3.22M |
|
836
Aaon
AAON
$7.77B
| $7.57M | 0.01% |
119,747
-216,876
| -64% | -$13.7M |
|
|
PSFE.WS
837
CALL
DELISTED
Paysafe Ltd Warrants
PSFE.WS
| $7.57M | 0.01% |
750,000
| – | – |
|
838
First Watch Restaurant Group
FWRG
$766M
| $7.56M | 0.01% |
447,415
+144,022
| +47% | +$2.38M |
|
839
ZipRecruiter
ZIP
$423M
| $7.55M | 0.01% |
+425,007
| New | +$6.99M |
|
840
Evolus
EOLS
$501M
| $7.54M | 0.01% |
1,036,874
+925,963
| +835% | +$7.99M |
|
841
Kontoor Brands
KTB
$4.26B
| $7.47M | 0.01% |
177,513
-41,738
| -19% | -$1.79M |
|
842
Liberty Media Series A
FWONA
$23.6B
| $7.45M | 0.01% |
115,040
-51,437
| -31% | -$3.25M |
|
843
Bio-Rad Laboratories Class A
BIO
$9.42B
| $7.44M | 0.01% |
19,613
-13,749
| -41% | -$5.6M |
|
844
W.R. Berkley
WRB
$26.6B
| $7.43M | 0.01% |
+187,125
| New | +$7.36M |
|
845
Spire
SR
$4.85B
| $7.42M | 0.01% |
+117,030
| New | +$7.85M |
|
846
Beazer Homes USA
BZH
$907M
| $7.41M | 0.01% |
+261,962
| New | +$5.34M |
|
847
Genesco
GCO
$422M
| $7.4M | 0.01% |
295,643
+276,543
| +1,448% | +$8.01M |
|
848
Fiverr
FVRR
$339M
| $7.4M | 0.01% |
284,454
+92,226
| +48% | +$2.78M |
|
|
SBDS
849
DELISTED
Solo Brands Inc
SBDS
| $7.4M | 0.01% |
32,665
+22,357
| +217% | +$5.56M |
|
850
PUT
Texas Instruments
TXN
$261B
| $7.34M | 0.01% |
+40,800
| New | +$7.02M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.